Leukemia, Myeloid, Accelerated Phase
"Leukemia, Myeloid, Accelerated Phase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The phase of chronic myeloid leukemia following the chronic phase (LEUKEMIA, MYELOID, CHRONIC-PHASE), where there are increased systemic symptoms, worsening cytopenias, and refractory LEUKOCYTOSIS.
| Descriptor ID |
D015465
|
| MeSH Number(s) |
C04.557.337.539.250.300 C15.378.190.636.370.300
|
| Concept/Terms |
Leukemia, Myeloid, Accelerated Phase- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myelogenous, Aggressive-Phase
- Leukemia, Myeloid, Accelerated-Phase
- Leukemia, Myeloid, Aggressive-Phase
- Myeloid Leukemia, Chronic, Aggressive-Phase
- Myelogenous Leukemia, Chronic, Aggressive-Phase
- Myeloid Leukemia, Chronic, Accelerated Phase
- Myeloid Leukemia, Chronic, Accelerated-Phase
- Myeloid Leukemia, Chronic, Aggressive Phase
- Leukemia, Myelogenous, Aggressive Phase
- Myelogenous Leukemia, Chronic, Aggressive Phase
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Myeloid, Accelerated Phase".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Leukemia [C04.557.337]
- Leukemia, Myeloid [C04.557.337.539]
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive [C04.557.337.539.250]
- Leukemia, Myeloid, Accelerated Phase [C04.557.337.539.250.300]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Bone Marrow Diseases [C15.378.190]
- Myeloproliferative Disorders [C15.378.190.636]
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive [C15.378.190.636.370]
- Leukemia, Myeloid, Accelerated Phase [C15.378.190.636.370.300]
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myeloid, Accelerated Phase".
This graph shows the total number of publications written about "Leukemia, Myeloid, Accelerated Phase" by people in this website by year, and whether "Leukemia, Myeloid, Accelerated Phase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Myeloid, Accelerated Phase" by people in Profiles.
-
Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy. Leukemia. 2010 Jul; 24(7):1299-301.
-
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia. Blood. 2008 Feb 15; 111(4):1834-9.
-
Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL(1). Leukemia. 2003 Apr; 17(4):691-9.
-
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia. Bone Marrow Transplant. 1999 May; 23(10):977-81.
-
Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors. Bone Marrow Transplant. 1996 Oct; 18(4):747-53.
-
The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia. Leukemia. 1995 Apr; 9(4):628-33.